-
Ivonescimab Receives NMPA Approval for First-Line Treatment of PD-L1-Positive NSCLC, Based on Breakthrough Head to Head Phase III Trial Demonstrating Superior Efficacy Over Pembrolizumab
25 Apr 2025 23:10 GMT
… University, commented:
“The Phase III HARMONi-2 study demonstrated … NSCLC. The recent Phase III trial combining ivonescimab … and bi-specific antibody drug development technology (Tetrabody) … 24 candidates have entered clinical trials (including 15 bispecific…
-
Sebela Pharma announces positive results from phase 3 TRIUMpH programme of tegoprazan in GERD
25 Apr 2025 13:02 GMT
… from two pivotal US phase 3 clinical trials evaluating tegoprazan, a novel … 2025 with a New Drug Application inclusive of both … disease (NERD). The phase 3 studies were conducted entirely … achieved statistical significance.
The phase 3 NERD study consisted of …
-
Onc.AI Announces Presentation of Breakthrough-Designated AI Model Evaluated in Clinical Trial Data at AACR 2025
25 Apr 2025 10:54 GMT
… GSK’s GARNET Phase I clinical trial (NCT02715284) Cohort E, that enrolled … process from Phase I to Phase III studies,” said George R. Simon … pharmaceutical leaders to accelerate oncology drug development. Onc.AI is backed …
-
Could investigational drug become first-in-class bronchiectasis therapy?
25 Apr 2025 22:46 GMT
… the Prescription Drug User Fee Act (PDUFA).
The largest clinical trial investigating a … pulmonary exacerbations. Findings from the Phase III ASPEN study of brensocatib could … the world’s largest bronchiectasis clinical trial
Brensocatib 25mg is the first …
-
Cobenfy Falls Short of Statistical Significance as Additional Treatment for Schizophrenia in Phase III Clinical Trial
24 Apr 2025 01:18 GMT
Bristol Myers Squibb has shared results from its Phase III ARISE trial evaluating Cobenfy (xanomeline and trospium chloride) as an add on therapy to atypical antipsychotics in adults with inadequately controlled symptoms of schizophrenia. Despite …
-
Akeso and Summit notch another Phase III win with their Keytruda competitor
24 Apr 2025 22:54 GMT
… primary endpoint in a Phase III trial in patients with … are running the multi-regional Phase III HARMONi-3 trial (NCT05899608) … 2028 patent expiration for the drug. Meanwhile, GlobalData predicts … is the parent company of Clinical Trials Arena.
Sign up for …
-
Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
24 Apr 2025 17:00 GMT
… therapies @ Sarcopenia Clinical Trials Sarcopenia Therapeutics Assessment … Assessment
5.
Sarcopenia Clinical Trial Therapeutics
6.
Sarcopenia … : Late-Stage Products (Phase III)
8.
Sarcopenia Pipeline: … trends, in emerging drugs, and competitive strategies. …
-
Global clinical trial to test existing drugs as long COVID treatments
24 Apr 2025 14:56 GMT
… of people, a new clinical trial led by scientists from … intelligence as two existing drugs that could interrupt several … of those pathways.
“Drug repurposing has the potential … , Uganda and Zambia, the Phase III, double-blind, placebo-controlled …
-
Summit Therapeutics (SMMT): Why Shares Jumped 21.50% on Breakthrough Phase 3 Results
24 Apr 2025 00:06 GMT
… Akeso, announced that their Phase 3 HARMONi-6 trial of … the company announced a clinical trial collaboration with Pfizer to … several of Pfizer’s antibody-drug conjugates (ADCs) across … positive results in multiple Phase 3 trials, outperforming some of …
-
New Drug Combination Offers Hope for Unresponsive Colon Cancer
25 Apr 2025 08:23 GMT
… chemotherapy, according to a Phase 3 clinical trial by researchers at City of … World Report.
The Food and Drug Administration (FDA) in January … is a monoclonal antibody drug used to treat colorectal … survival analysis of the Phase III CodeBreaK 300 Study of …